Osaka, Japan

Katsufumi Kajimoto

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Osaka University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katsufumi Kajimoto. Retrieved from https://idiyas.com/inventor/katsufumi-kajimoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Katsufumi Kajimoto in Liver Disease Management.

Introduction

Katsufumi Kajimoto is an accomplished inventor based in Osaka, Japan. He has made significant contributions to the field of medical science, particularly in the management of liver diseases. His innovative approach focuses on dietary interventions that can improve health outcomes for patients suffering from liver conditions.

Latest Patents

Katsufumi Kajimoto holds a patent for a sugar-restricted, high-fat diet aimed at improving liver disease. This invention outlines a dietary regimen where daily fat intake is set at 120 grams or more based on a real body weight of 50 kg, or at an amount corresponding to 70% or more of the total daily energy intake. The diet is designed to reduce body fat mass and lower levels of AST, ALT, and γ-GTP in patients with nonalcoholic fatty liver disease. He has 1 patent to his name.

Career Highlights

Katsufumi Kajimoto is affiliated with Osaka University, where he conducts research and develops innovative solutions for health issues. His work has garnered attention for its potential to transform dietary practices in the management of liver diseases.

Collaborations

Katsufumi collaborates with Keisuke Hagihara, contributing to advancements in their shared field of research.

Conclusion

Katsufumi Kajimoto's innovative dietary approach represents a significant advancement in the management of liver disease. His contributions continue to influence the medical community and improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…